In summary, our study found IGF2BP3 up‐regulation exerted the positive biological role to promote the cell proliferation ability of bladder cancer cells in vitro and in vivo by modulating the JAK/STAT pathway. This evidence concerns the gene IGF2BP3 and urinary bladder cancer.